Rheumatology health professionals seeking continuing education should include the ACR/ARHP Annual Scientific Meeting on their list of must-attend meetings. No other conference offers more in rheumatic disease education and research, and this meeting provides a forum to network with over 11,000 physicians, scientists, and health professionals.
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
Unique Meeting Accelerates RA Research
More than 50 rheumatoid arthritis (RA) investigators from across the U.S. recently met in Ft. Worth, Texas, to share information, present data and results from their innovative RA research projects, and brainstorm ways to work more closely together to find a cure for the disease.
Congress Approves Six-Month “Doc Fix”—Now What?
Congress’ May 24 vote to rescind the 21% Medicare pay cut for six months illustrates how important it is for rheumatology professionals and patients to be involved in the legislative process. It was the thousands of calls, e-mails, and letters from medical professionals and patients that spurred Congress to take action. However, the battle is not yet over. Medicare physician payments face the same 21% cut beginning December 1.
Letter to the Editor: Comments on July’s Ethics Forum
Feedback from our Readers
REF’s Campaign to Support RA Research Nears its Initial Funding Target
The REF’s campaign to support RA research nears its initial funding target
The Key to Early Rheumatoid Arthritis
The conundrum of classification versus diagnosis
Mitigate Risk and Increase Success of Lupus Clinical Trials
Design strategies from a Lupus Research Institute conference
A Look Back & A Look Ahead: ACR Research and Education Foundation Turns 25
The ACR Research and Education Foundation turns 25
What is ICD-9 Coding?
The International Classification of Diseases Clinical Modification, 9th Revision (ICD-9 CM) is a list of codes intended for the classification of diseases and a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or disease. The numerical format of the diagnosis codes usually ranges from three to five digits that are assigned to a unique category.
Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction
A study recently published in Annals of the Rheumatic Diseases shows promise for potential new therapies to prevent bone loss and bone destruction in patients with rheumatoid arthritis (RA).
- « Previous Page
- 1
- …
- 273
- 274
- 275
- 276
- 277
- …
- 305
- Next Page »